跳至主要内容
临床试验/JPRN-UMIN000007945
JPRN-UMIN000007945招募中2 期

Safety and efficacy of lenalidomide and prednisone therapy in Japanese elderly patients with multiple myeloma, a phase II study - Safety and efficacy of lenalidomide and prednisone therapy in Japanese elderly patients with multiple myeloma, a phase II study

ara Hospital Kinki University School Of Medicine0 个研究点目标入组 15 人开始时间: 2012年5月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • .Cardiac infarction within 6 months .Deep vein thrombosis or pulmonary embolism within 3 years .Tuberculosis, herpes simplex keratitis, mycosis, or other active infections at baseline .Uncontrollable diabetes mellitus, hypertension, peptic ulcer, or glaucoma .Posterior capsule opacification .Patients with mental illness .Those who are considered as inappropriate to register by attending physicians .Pregnant or breast feeding females .Known hypersensitivity to prednisone

研究者

发起方
ara Hospital Kinki University School Of Medicine

相似试验